ConCallIQ
Go Pro
AGARWALEYE Diversified 10 Feb 2026

Dr. Agarwal's Health Care Limited — Q3 FY26

Dr.

bullish high
Compare with...
Revenue ₹530 Cr +23%
EBITDA ₹155 Cr +21.3%
PAT ₹44 Cr +55%
EBITDA Margin 28.4%
Duration 52 min
Read Time 1 min read

✓ Verified against BSE filing

Delivery score0%
Due this quarter2
Delivered0
Missed2

Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.

Q1 FY26

42 new facilities in next three quarters

Management targets launching 42 new facilities across India, with 23 in the south, 9 in the west, 5 in the north, and 5 in the east.

Missed

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

heuristic_v1
Q1 FY26

FY26 capex of ₹310 crore

Capex guidance for FY26 remains unchanged at ₹310 crore, supporting the expansion plan.

Missed

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

heuristic_v1